A
Andrew J. Martin
Researcher at University of New South Wales
Publications - 897
Citations - 43053
Andrew J. Martin is an academic researcher from University of New South Wales. The author has contributed to research in topics: Medicine & Academic achievement. The author has an hindex of 84, co-authored 819 publications receiving 36203 citations. Previous affiliations of Andrew J. Martin include University of Western Australia & Max Planck Society.
Papers
More filters
Why do people not attend NHS Health Checks? A systematic review and qualitative synthesis
What Motivates Students to Study Abroad? A Comparison of Australia and Scotland's Academic Tourism Sector
TL;DR: This paper explored the field of academic tourism, whereby international students study abroad for a period of time and found that the main motivational factors that influenced the students included the drive to have a unique experience, escape from daily life, the natural environment and scenery, recreational activities and self-discovery.
Journal ArticleDOI
Adding mitomycin to Bacillus Calmette-Guerin as adjuvant intravesical therapy for high-risk, nonmuscle-invasive urothelial bladder cancer (BCGMM; ANZUP 1301)
Elizabeth Chien Hern Liow,Dickon Hayne,Martin R. Stockler,Andrew J. Martin,Shomik Sengupta,Paul Anderson,Kate Ford,Mark Frydenberg,Margot Gorzeman,Will Green,Jeremy Grummet,Cynthia Hawks,Laurence Eliot Miles Krieger,Joseph Ischia,Steve P. McCombie,Manish I. Patel,Ian D. Davis,New Zealand Urogenital +17 more
TL;DR: Adjuvant intravesical bacillus Calmette-Guerin decreases disease recurrence and progression in people with high-risk, non-muscle invasive urothelial bladder cancer (NMIBC).
Journal ArticleDOI
Unwrapped: An unexpected association with the absorbable antibacterial envelope
TL;DR: The use of TYRX envelope has been shown in prior studies to reduce the risk of CIED infections as well as Twiddler's syndrome, although not in the 2 cases we have described as mentioned in this paper .
Germline V-H/V-L pairing in antibodies
TL;DR: It is found that pairing preferences do exist in the germline, but only for a small proportion of germline gene segments; others are much more promiscuous showing no preferences, which may impact on the ability to generate more stable antibodies for use as biopharmaceuticals.